Related Experiment Videos
An industrial process for synthesizing Lodenosine (FddA)
Kunisuke Izawa1, Satoshi Takamatsu, Satoshi Katayama
1AminoScience Laboratories, Ajinomoto Co., Inc., Kawasaki-ku, Kawasaki, Japan. kunisuke_izawa@ajinomoto.com
Nucleosides, Nucleotides & Nucleic Acids
|October 21, 2003
Summary
Two industrial synthetic routes for Lodenosine (FddA) were developed using purine riboside or 3'-deoxyriboside precursors. Novel deoxygenation and fluorination methods were evaluated for efficiency, cost, safety, and environmental impact.
Area of Science:
- Organic Chemistry
- Medicinal Chemistry
- Process Chemistry
Background:
- Lodenosine (9-(2,3-dideoxy-2-fluoro-beta-D-threo-pentofuranosyl) adenine) is a nucleoside analog with potential therapeutic applications.
- Efficient and scalable synthesis of modified nucleosides is crucial for drug development.
Purpose of the Study:
- To describe two distinct industrial synthetic approaches for Lodenosine (FddA).
- To compare novel deoxygenation and fluorination methodologies for their application in Lodenosine synthesis.
Main Methods:
- Synthesis via a purine riboside precursor.
- Synthesis via a purine 3 -deoxyriboside precursor.
- Comparative analysis of deoxygenation and fluorination techniques.
Main Results:
- Successful development of two viable industrial synthetic routes to Lodenosine.
- Evaluation of reaction yields, economic feasibility, safety protocols, and environmental considerations for each method.
- Identification of novel applications for deoxygenation and fluorination in nucleoside synthesis.
Conclusions:
- The study presents scalable synthetic strategies for Lodenosine production.
- The comparative analysis provides valuable insights for selecting optimal synthetic methods based on yield, cost, safety, and environmental factors.
- The findings contribute to the advancement of modified nucleoside synthesis for pharmaceutical applications.